Litcius/Paper detail

Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial

Huafeng Wang, Liping Mao, Min Yang, Pengxu Qian, Huan Lu, Hongyan Tong, Wanzhuo Xie, De Zhou, Xin Huang, Yungui Wang, Gaixiang Xu, Ying Lu, Juying Wei, Wenyuan Mai, Xiujin Ye, Haitao Meng, Yaojia Shen, Jian Huang, Wenjuan Yu, Jie Sun, Jianpeng Sheng, Xiaoyan Yan, Jie Jin, Hong‐Hu Zhu

2022The Lancet Haematology107 citationsDOI

Topics & Concepts

MedicineCytarabineVenetoclaxInternal medicineDaunorubicinRegimenChemotherapy regimenClinical endpointInduction chemotherapyAdverse effectMyeloidChemotherapyOncologyGastroenterologyLeukemiaClinical trialChronic lymphocytic leukemiaAcute Myeloid Leukemia ResearchNeutropenia and Cancer InfectionsAcute Lymphoblastic Leukemia research